Your browser doesn't support javascript.
loading
FLT3 inhibitors potentially improve response rates in acute myeloid leukemia harboring t(6;9)(DEK::NUP214): The Mayo Clinic experience.
Csizmar, Clifford M; Saliba, Antoine N; Greipp, Patricia T; Alkhateeb, Hassan; Begna, Kebede H; Foran, James M; Gangat, Naseema; Hogan, William J; Hook, C Christopher; Litzow, Mark R; Mangaonkar, Abhishek A; Palmer, Jeanne M; Pardanani, Animesh; Shah, Mithun V; Tefferi, Ayalew; Torghabeh, Mehrdad Hefazi; Wolanskyj-Spinner, Alexandra P; Patnaik, Mrinal M; Kaufmann, Scott H; Al-Kali, Aref.
Affiliation
  • Csizmar CM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
  • Saliba AN; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
  • Greipp PT; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
  • Alkhateeb H; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
  • Begna KH; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
  • Foran JM; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Jacksonville, FL.
  • Gangat N; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
  • Hogan WJ; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
  • Hook CC; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
  • Litzow MR; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
  • Mangaonkar AA; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
  • Palmer JM; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ.
  • Pardanani A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
  • Shah MV; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
  • Tefferi A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
  • Torghabeh MH; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
  • Wolanskyj-Spinner AP; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
  • Patnaik MM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
  • Kaufmann SH; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN. kaufmann.scott@mayo.edu.
  • Al-Kali A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN. alkali.aref@mayo.edu.
Haematologica ; 2024 Jun 20.
Article in En | MEDLINE | ID: mdl-38899336
ABSTRACT
Not available.
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Haematologica Year: 2024 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Haematologica Year: 2024 Document type: Article